Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on Tuesday. Novo's revised offer ...

Tech stocks led a selloff in the first minutes of trading on Monday as doubts about high-running valuations preyed on ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Sarepta Therapeutics' shares plunged nearly 40% in premarket trading on Tuesday as failure of two of its approved drugs for a ...

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

Analyst Edison Lee wrote that delivery lead times for the 17 Air and 17 Pro have stabilized, but the base model continues to ...

() -Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...

Tech led a sharp pullback in US stock futures on Tuesday as doubts about the AI-fueled rally crept in and investors waited ...

Palantir (PLTR) stock fell Tuesday as Wall Street analysts debated whether its latest solid earnings report justified its ...

China’s Commerce Ministry said Tuesday that the Netherlands’ seizure of Chinese-owned chipmaker Nexperia has caused “chaos” ...

Ferrari has trimmed price increases on some of the models it sells in the U. to a maximum of 5% following a deal to reduce ...